Details for New Drug Application (NDA): 215508
✉ Email this page to a colleague
The generic ingredient in EDARAVONE is edaravone. Four suppliers are listed for this compound. Additional details are available on the edaravone profile page.
Summary for 215508
Tradename: | EDARAVONE |
Applicant: | Hikma |
Ingredient: | edaravone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 30MG/100ML (0.3MG/ML) | ||||
Approval Date: | May 6, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription